DAVID WILKINS: Open Payments
NPI 1740230200 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,276 in 243 payments from 34 companies in 2025. Trend: 2023 $11,618 · 2024 $7,631 · 2025 $10,276
Speaker / faculty: $5,750Food & beverage: $4,273Travel & lodging: $197Education: $56
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $6,369 |
| ABBVIE INC. | 42 | $620 |
| Supernus Pharmaceuticals, Inc. | 26 | $385 |
| Novo Nordisk Inc | 16 | $295 |
| PFIZER INC. | 16 | $284 |
| Alkermes, Inc. | 12 | $283 |
| AstraZeneca Pharmaceuticals LP | 7 | $215 |
| Axsome Therapeutics, Inc. | 7 | $193 |
| GlaxoSmithKline, LLC. | 18 | $173 |
| Otsuka America Pharmaceutical, Inc. | 9 | $160 |
Products named: REPATHA, Qelbree, ARISTADA, LINZESS, NURTEC ODT, FARXIGA, CAPLYTA, Ozempic.
Industry payments across MI — which companies pay providers there.
